[The use of radiosensitizing agents in radiotherapy].
D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D001973:Bromodeoxyuridine / Q000627:therapeutic use; D004247:DNA / Q000378:metabolism; D003609:Dactinomycin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D010100:Oxygen / Q000627:therapeutic use; D012313:RNA / Q000378:metabolism; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D014812:Vitamin K / Q000627:therapeutic use
D011838:Radiation-Sensitizing Agents; D014812:Vitamin K; D003609:Dactinomycin; D012313:RNA; D006003:Glycogen; D004247:DNA; D001973:Bromodeoxyuridine; D010100:Oxygen; D005472:Fluorouracil
Die Anwendung strahlensensibilisierender Substanzen in der Strahlentherapie.